RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Clinical trials for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
No-Cell-Collection CAR-T: new shot at blood cancer remission?
Disease control Not yet recruitingThis early study tests a new treatment called DIT101 for people with blood cancers that have come back or stopped responding to standard therapy. DIT101 is a type of CAR-T therapy that works inside the body, so patients don't need to have their cells collected and modified in a l…
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Tcelltech Inc. • Aim: Disease control
Last updated May 26, 2026 09:58 UTC
-
New hope for tough blood cancers: BT02 trial launches
Disease control Not yet recruitingThis study tests a new drug called BT02 in people with blood cancers (leukemia, lymphoma, or multiple myeloma) that have returned or not responded to treatment. About 116 adults aged 18 to 70 will receive the drug by IV every 2-3 weeks for up to 2 years. The main goals are to che…
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: Biotroy Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:54 UTC